Concepedia

Casey Johnson

CJ

Statistics

Publications

17

Citations

2.3K

H-Index

15

Active since

1999

Affiliations

Johnson County Clin-Trials (United States)(Current)

VaxInnate (United States)

Abcam (United States)

GlaxoSmithKline (United States)

University of Antwerp

Casey Johnson is an author at Johnson County Clin-Trials (United States) specializing in vaccinology, infectious diseases, and immunization.

Publications per year

1999–2021

17

Publications

17

Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent Influenza

Frederick G. Hayden, Robert L. Atmar, M. Schilling et al. · New England Journal of Medicine · 1999 · 517 citations · Full text

, , +15

Safety and immunogenicity of a recombinant M2e–flagellin influenza vaccine (STF2.4xM2e) in healthy adults

Christine B. Turley, Richard Rupp, Casey Johnson et al. · Vaccine · 2011 · 293 citations

, , +12

A live, attenuated recombinant West Nile virus vaccine

Thomas P. Monath, Jian Liu, Niranjan Kanesa-thasan et al. · Proceedings of the National Academy of Sciences · 2006 · 227 citations · Full text

, , +17

Clinical proof of principle for ChimeriVax™: recombinant live, attenuated vaccines against flavivirus infections

Thomas P. Monath, Karen McCarthy, Philip Bedford et al. · Vaccine · 2002 · 220 citations

, , +16

Chimeric Live, Attenuated Vaccine against Japanese Encephalitis (ChimeriVax‐JE): Phase 2 Clinical Trials for Safety and Immunogenicity, Effect of Vaccine Dose and Schedule, and Memory Response to Challenge with Inactivated Japanese Encephalitis Antigen

Thomas P. Monath, Farshad Guirakhoo, Richard Nichols et al. · The Journal of Infectious Diseases · 2003 · 216 citations

, , +17

1–5 of 17